MedPath

Improving Outcomes in Underserved Women With GDM

Not Applicable
Completed
Conditions
Pregnancy
Diabetes Mellitus
Registration Number
NCT00774124
Lead Sponsor
Temple University
Brief Summary

Our objective is to test an innovative approach to improve outcomes among underserved women with gestational diabetes. We ill utilize a multi-lingual, Interactive Voice Response (IVR) -enabled telephone system to facilitate diabetes control and thereby improve pregnancy outcomes. Our hypothesis is that Telemonitoring will improve maternal glycemia, thereby reducing infant birth weights and leading to improved pregnancy outcomes.

Detailed Description

Using a step care design, women will be randomized into standard of care or Telemonitoring. In the standard of care group, women will monitor their blood glucose levels four times a day, perform fetal movement counting three times a day and also record insulin doses. The women will record this information in a logbook, which will be reviewed by the medical team at prenatal visits. In the Telemonitoring group, women will receive the standard of care anmd will also transmit their blood glucose and fetal movement information to their health care providers.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
57
Inclusion Criteria
  • diagnosis of GDM
  • 33 or less weeks gestation
Exclusion Criteria
  • multiple gestations
  • history of glucose intolerance outside of pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
maternal blood glucose control3 to 9 months
Secondary Outcome Measures
NameTimeMethod
infant birthweightat delivery

Trial Locations

Locations (2)

Tallahassee Memorial Diabetes Center

πŸ‡ΊπŸ‡Έ

Tallahassee, Florida, United States

Temple University Hospital

πŸ‡ΊπŸ‡Έ

Philadelphia, Pennsylvania, United States

Tallahassee Memorial Diabetes Center
πŸ‡ΊπŸ‡ΈTallahassee, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.